Final Selection
With pride we announce the final selection for Samsung For Impact Switzerland 2020:
PIPRA AG
PIPRA developed an A.I. based preoperative risk assessment tool objectively determining a patients risk of postoperative delirium. Postoperative delirium in the elderly has a 25% mortality rate within one month, doubles nursing home admissions and in 38% of cases leads to long-term dementia. Detecting the high-risk patients before surgery reduces the incidence and helps keep the elderly healthy for longer.
PIPRA helps clinicians pre-surgically evaluate a patient’s risk by unbiased, data-driven scores calculated from risk factors, allowing for protective perioperative measures
Emovo Care
Emovo is a medical device robotic hand orthosis for stroke victims. Patent-pending artificial tendons enables us to build a unique device to assist/rehabilitate directly at home. Stroke is one of the leading causes of adult disabilities worldwide today, and it is expected to steadily grow due to population ageing. Emovo’s system enables them to bring care directly at home, reducing costs and secondary complications due to limited healthcare coverage.
P2 Solutions
P2 developed intelligent diapers for elderly care centers to accurately measure pee and feces and thus simplify the work of caregivers. During the night, caregivers wake up the elderly to change their diapers regardless of its content. Their software proposes routines to caregivers that calculate when diapers are full, preventing leakages and bedsores of the elderly. In doing so, the elderly receive a more pleasant experience.
We+Care
We+Care is an integrated Swiss care coordination platform for distance carers of older people. As four out of five 80-year-olds live at home and 70% of the care is provided by 600’000 informal carers, We+Care is tapping the untapped knowledge of carers and helps create the ‘optimal care’ solution by making informed decisions on how to setup and coordinate a cost-efficient care network.
Senopi AG
Senopi developed a proprietary platform enabling caregivers to control seniors’ VR experiences and is currently developing digital therapeutics to monitor and prevent age-related frailty and cognitive decline. It is a scalable solution for prolonging healthy lives and promoting seniors’ well-being.
We are super excited and very proud of the selection. We look forward to working together with these impact driven startups.
Our Ageing Society
Acceleration Program
The Samsung For Impact program helps you take your startup to the next level and prepare for your first/next round of investment. The content of the 12-week program has been carefully designed to meet the needs of early-stage startups in the field of ageing society. At the end of the program, your business should have developed, and you will have the chance to pitch your startup in front of different startup and impact investors as well as Samsung representatives.
Selection Criteria
To participate in the Samsung For Impact program, your startup should meet the following criteria:
Timeline
Initiators
Samsung seeks to be a truly responsible corporate citizen in each of its global locations through initiatives designed to solve the most pressing problems. In doing so it addresses issues that are unique for each community, maximizing its impact through working with its subsidiaries and specialized local organizations. Samsung For Impact is one of those initiatives and it is being implemented in four European countries.
Bluelion is a Zurich-based startup incubator on a mission to help tech startups to get from 0 to 1. With office space, coaching and networking opportunities, Bluelion supports pre-seed and seed startups in getting traction and visibility for their businesses.
SEIF offers specialized coaching, training & development, consulting and impact investment opportunities to support impact driven entrepreneurs to drive their businesses, tap the market, grow and scale successfully.Apply
Does your startup meet the challenges and opportunities of the ageing society? Apply now for the Samsung For Impact program.
FAQs
